IBM Watson keeps on making progress in the oncology field
The ASCO 2017, the annual Meeting of the American Society of Clinical Oncology (ASCO), new data were presented regarding the experimentation of Watson for Oncology, the version of IBM’s cognitive computing system trained to recognize the symptoms of various forms of cancer and suggest a therapy. Developed within the Watson Health business unit, it showed a level of agreement with human doctors that reached 96% in cases of lung cancer.



